Merck & Co Inc (MRK)
127.16
-0.35
(-0.27%)
USD |
NYSE |
May 06, 13:24
Merck SG&A Expense (Annual): 10.50B for Dec. 31, 2023
SG&A Expense (Annual) Chart
Historical SG&A Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 10.50B |
| December 31, 2022 | 10.04B |
| December 31, 2021 | 9.634B |
| December 31, 2020 | 8.955B |
| December 31, 2019 | 9.455B |
| December 31, 2018 | 10.10B |
| December 31, 2017 | 10.07B |
| December 31, 2016 | 10.02B |
| December 31, 2015 | 10.31B |
| December 31, 2014 | 11.61B |
| December 31, 2013 | 11.91B |
| December 31, 2012 | 12.78B |
| December 31, 2011 | 13.73B |
| December 31, 2010 | 13.12B |
| December 31, 2009 | 8.543B |
| December 31, 2008 | 7.377B |
| December 31, 2007 | 7.557B |
| December 31, 2006 | 8.165B |
| December 31, 2005 | 7.156B |
| December 31, 2004 | 7.239B |
| Date | Value |
|---|---|
| December 31, 2003 | 6.200B |
| December 31, 2002 | 5.652B |
| December 31, 2001 | 5.701B |
| December 31, 2000 | 6.168B |
| December 31, 1999 | 5.200B |
| December 31, 1998 | 4.511B |
| December 31, 1997 | 4.299B |
| December 31, 1996 | 3.841B |
| December 31, 1995 | 3.298B |
| December 31, 1994 | 3.178B |
| December 31, 1993 | 2.914B |
| December 31, 1992 | 4.075B |
| December 31, 1991 | 3.558B |
| December 31, 1990 | 3.242B |
| December 31, 1989 | 2.764B |
| December 31, 1988 | 2.547B |
| December 31, 1987 | 2.248B |
| December 31, 1986 | 1.750B |
| December 31, 1985 | 1.331B |
| December 31, 1984 | 1.237B |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Annual) Range, Past 5 Years
8.955B
Minimum
2020
10.50B
Maximum
2023
9.718B
Average
9.634B
Median
2021
SG&A Expense (Annual) Benchmarks
| Amgen Inc | 6.179B |
| Johnson & Johnson | 20.11B |
| Eli Lilly and Co | 6.941B |
| Pfizer Inc | 14.77B |
| Moderna Inc | 1.549B |